MarketPeel
Insider Trading Intelligence
Pricing
…
JK

Jack A. Khattar

SUPN
PRESIDENT, CEO · SUPERNUS PHARMACEUTICALS, INC. · CIK 0001539937
FILING MIX · LIFETIME45%/55%
BUYS
94
SELLS
113
TOTAL VALUE
$61.08M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,031,600
AVG SELL PX
$39.39
TRADE KIND
SHOWING 207 / 207
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
40 backtested trades · 8 horizons · 43 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jack A. Khattar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d40+35.00%+0.48%+0.17%+0.30%+0.14%0.49
14d40+25.00%+1.89%-0.46%+2.35%+2.16%3.04
30d40+17.50%+4.69%+0.05%+4.64%+5.91%4.09
60d40+37.50%+2.76%+0.42%+2.33%-0.10%1.27
90d40+30.00%+4.61%+1.90%+2.70%+2.86%1.33
180d40(3 pending)+32.43%+2.93%+3.93%-1.00%+5.04%-0.29
1y40(19 pending)+71.43%-14.33%+15.60%-29.94%-36.18%—
2y40(21 pending)+42.11%-1.54%+46.19%-47.73%-50.28%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SUPN · 958,100 shares · as of Mar 13, 2026
0316,620633,239949,8591,266,478202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 94 buys / 113 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
25,000——73,500Jun 17, 2026Jun 22, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
24,138$50.09$1.21M968,962Mar 13, 2026Mar 16, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
12,500——993,100Mar 13, 2026Mar 16, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,742$51.00$547.8K958,220Mar 13, 2026Mar 16, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
12,500——1,241,144Mar 13, 2026Mar 16, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
120$51.75$6.2K958,100Mar 13, 2026Mar 16, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
38,640——0Mar 6, 2026Mar 10, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,574$54.73$907.1K1,228,644Mar 6, 2026Mar 10, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
38,640——1,245,218Mar 6, 2026Mar 10, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
38,640——38,640Feb 28, 2026Mar 3, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
341,610——341,610Feb 18, 2026Feb 20, 2026 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
58,371$50.55$2.95M1,208,107Oct 9, 2025Oct 10, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
81,250$25.30$2.06M1,266,478Oct 9, 2025Oct 10, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,529$51.46$78.7K1,206,578Oct 9, 2025Oct 10, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
81,250——0Oct 9, 2025Oct 10, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
2,267——81,250Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
2,267$25.30$57.4K1,163,137Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,904$48.06$91.5K1,161,233Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
20,000——0Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
7,529$46.21$347.9K1,185,228Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
19,320——1,192,757Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
19,320——0Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
7,796$46.21$360.3K1,173,437Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
20,000——1,181,233Oct 2, 2025Oct 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
53,785$25.30$1.36M1,201,043Oct 1, 2025Oct 2, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40,173$48.07$1.93M1,160,870Oct 1, 2025Oct 2, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
53,785——83,517Oct 1, 2025Oct 2, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
11,510$25.30$291.2K1,155,846Sep 30, 2025Oct 1, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,588$48.25$414.4K1,147,258Sep 30, 2025Oct 1, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
11,510——137,302Sep 30, 2025Oct 1, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,235$48.02$491.5K1,144,336Sep 29, 2025Sep 30, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
13,688——148,812Sep 29, 2025Sep 30, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
13,688$25.30$346.3K1,154,571Sep 29, 2025Sep 30, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
47,940——0Sep 23, 2025Sep 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
29,513$47.23$1.39M1,140,883Sep 23, 2025Sep 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
47,940$12.98$622.3K1,170,396Sep 23, 2025Sep 24, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
27,060——47,940Sep 22, 2025Sep 23, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
16,587$47.02$779.9K1,122,456Sep 22, 2025Sep 23, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
27,060$12.98$351.2K1,139,043Sep 22, 2025Sep 23, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Sep 10, 2025Sep 12, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,320——19,320Sep 10, 2025Sep 12, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
8,074——162,500Sep 8, 2025Sep 9, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
8,074$25.30$204.3K1,118,305Sep 8, 2025Sep 9, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,322$46.29$292.6K1,111,983Sep 8, 2025Sep 9, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
73,176$25.30$1.85M1,165,809Sep 5, 2025Sep 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
73,176——170,574Sep 5, 2025Sep 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
55,578$46.01$2.56M1,110,231Sep 5, 2025Sep 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
38,779——75,000Aug 28, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
24,150$45.12$1.09M1,092,633Aug 28, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
38,779$12.98$503.4K1,116,783Aug 28, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,650$45.05$479.8K1,078,004Aug 27, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
17,195——113,779Aug 27, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
17,195$12.98$223.2K1,088,654Aug 27, 2025Aug 29, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
1,611$12.98$20.9K1,072,459Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
1,611——130,974Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,000$45.00$45.0K1,071,459Aug 25, 2025Aug 27, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
2,415——132,585Aug 22, 2025Aug 26, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,500$45.00$67.5K1,070,848Aug 22, 2025Aug 26, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
2,415$12.98$31.3K1,072,348Aug 22, 2025Aug 26, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
60,000——195,000Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
81,250——243,750Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
81,250$25.30$2.06M1,133,433Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
60,000$12.98$778.8K1,068,683Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
63,500$43.12$2.74M1,069,933Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
38,500$40.24$1.55M1,030,183Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
60,000——135,000Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
38,000$42.00$1.60M1,052,183Aug 6, 2025Aug 8, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
60,000$12.98$778.8K1,090,183Aug 6, 2025Aug 8, 2025 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
34,000——48,500Jun 18, 2025Jun 23, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,850——1,005,600Apr 2, 2025Apr 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
16,850——1,008,683Apr 2, 2025Apr 3, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,805$32.06$538.8K991,833Mar 10, 2025Mar 11, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
35,000——1,008,638Mar 10, 2025Mar 11, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
35,000——0Mar 10, 2025Mar 11, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
38,640——0Mar 7, 2025Mar 7, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
18,581$39.11$726.7K973,638Mar 7, 2025Mar 7, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
38,640——992,219Mar 7, 2025Mar 7, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 28, 2025Mar 4, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
331,660——331,660Feb 20, 2025Feb 21, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
38,640——38,640Feb 17, 2025Feb 19, 2025 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
6,666$35.59$237.2K953,579Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
14,000——960,245Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
38,640——0Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
38,640——964,812Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
14,000——0Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
18,567$35.59$660.8K946,245Dec 27, 2024Dec 30, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
38,640——38,640Dec 23, 2024Dec 24, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Dec 23, 2024Dec 24, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
125,000$9.13$1.14M1,051,172Nov 8, 2024Nov 12, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
125,000——0Nov 8, 2024Nov 12, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
125,000$36.29$4.54M926,172Nov 8, 2024Nov 12, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
125,000$36.68$4.58M926,172Nov 7, 2024Nov 8, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
125,000——125,000Nov 7, 2024Nov 8, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
125,000$9.13$1.14M1,051,172Nov 7, 2024Nov 8, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
10,045$34.90$350.6K926,172Sep 3, 2024Sep 3, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
21,000——936,217Sep 3, 2024Sep 3, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
21,000——0Sep 3, 2024Sep 3, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,000——21,000Aug 27, 2024Aug 27, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——14,500Jun 7, 2024Jun 11, 2024 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,500——8,500Jun 7, 2024Jun 11, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
35,000——932,005Feb 28, 2024Feb 29, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,788$27.94$469.1K915,217Feb 28, 2024Feb 29, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
35,000——0Feb 28, 2024Feb 29, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
322,000——322,000Feb 22, 2024Feb 26, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
16,500——897,005Feb 12, 2024Feb 22, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,500——1,022,450Feb 12, 2024Feb 22, 2024 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
25,000——892,463Dec 22, 2023Dec 26, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
25,000——0Dec 22, 2023Dec 26, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
11,958$27.66$330.8K880,505Dec 22, 2023Dec 26, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Dec 14, 2023Dec 18, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
35,000——0Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
35,000——884,267Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
16,804$32.10$539.4K867,463Sep 7, 2023Sep 7, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
35,000——35,000Aug 23, 2023Aug 25, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,000——6,000Jun 9, 2023Jun 13, 2023 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,000——6,000Jun 9, 2023Jun 13, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
31,250——0May 11, 2023May 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
31,250——864,272May 11, 2023May 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
15,005$36.47$547.2K849,267May 11, 2023May 12, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
31,250——31,250May 4, 2023May 8, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
20,000——0Mar 14, 2023Apr 10, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
20,000——833,022Mar 14, 2023Apr 10, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
280,000——280,000Feb 23, 2023Feb 27, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——20,000Feb 16, 2023Feb 21, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
8,750——813,022Feb 15, 2023Feb 16, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
8,750——1,038,950Feb 15, 2023Feb 16, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
330$9.56$3.2K804,472Feb 3, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
200$42.02$8.4K804,272Feb 3, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
330——25,037Feb 3, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
22,515——25,367Feb 2, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
13,532$42.06$569.1K804,142Feb 2, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
22,515$9.56$215.2K817,674Feb 2, 2023Feb 6, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
300$42.01$12.6K795,159Feb 1, 2023Feb 3, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
498$9.56$4.8K795,459Feb 1, 2023Feb 3, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
498——47,882Feb 1, 2023Feb 3, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
976$42.01$41.0K794,961Jan 31, 2023Feb 2, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
1,620——48,380Jan 31, 2023Feb 2, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
1,620$9.56$15.5K795,937Jan 31, 2023Feb 2, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
8,080$9.56$77.2K799,253Jan 18, 2023Jan 20, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
4,936$40.40$199.4K794,317Jan 18, 2023Jan 20, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
8,080——50,000Jan 18, 2023Jan 20, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
41,920——58,080Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
25,446$40.03$1.02M791,173Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
41,920$9.56$400.8K816,619Jan 17, 2023Jan 19, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
18,472$9.56$176.6K826,053Dec 21, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,625——807,581Dec 21, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
11,354$38.14$433.1K814,699Dec 21, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
6,528——118,472Dec 20, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
4,006$38.02$152.3K791,956Dec 20, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
6,528$9.56$62.4K795,962Dec 20, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
18,472——100,000Dec 20, 2022Dec 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
11,135$35.18$391.7K789,434Nov 25, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
17,794——125,000Nov 25, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
17,794$9.56$170.1K800,569Nov 25, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
3,616$9.56$34.6K785,034Nov 23, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
2,259$35.05$79.2K782,775Nov 23, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
3,616——142,794Nov 23, 2022Nov 28, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
600$35.00$21.0K781,418Nov 22, 2022Nov 23, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
959——146,410Nov 22, 2022Nov 23, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
959$9.56$9.2K782,018Nov 22, 2022Nov 23, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
531$35.01$18.6K781,059Nov 21, 2022Nov 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
848——147,369Nov 21, 2022Nov 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
848$9.56$8.1K781,590Nov 21, 2022Nov 22, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
1,783$9.56$17.0K781,857Nov 15, 2022Nov 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
1,783——148,217Nov 15, 2022Nov 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
1,115$35.00$39.0K780,742Nov 15, 2022Nov 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
5,895——781,454Sep 14, 2022Sep 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
5,895——0Sep 14, 2022Sep 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
1,380$33.75$46.6K780,074Sep 14, 2022Sep 15, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
39,530——5,895Aug 16, 2022Aug 18, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
39,530——799,431Aug 16, 2022Aug 18, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
9,182$34.01$312.3K790,249Aug 16, 2022Aug 18, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
14,690$34.01$499.7K775,559Aug 16, 2022Aug 18, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
10,813$34.03$367.9K777,203Aug 15, 2022Aug 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
46,575——45,425Aug 15, 2022Aug 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
46,575——788,016Aug 15, 2022Aug 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
17,302$34.03$588.8K759,901Aug 15, 2022Aug 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
28,437$31.22$887.8K741,441Aug 10, 2022Aug 11, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
44,900——0Aug 10, 2022Aug 11, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
44,900——769,878Aug 10, 2022Aug 11, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
63,100——764,409Aug 9, 2022Aug 10, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
63,100——44,900Aug 9, 2022Aug 10, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
39,431$31.15$1.23M724,978Aug 9, 2022Aug 10, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
107,875$31.40$3.39M711,341Aug 8, 2022Aug 9, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
192,000——819,216Aug 8, 2022Aug 9, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
192,000——108,000Aug 8, 2022Aug 9, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
10,032$32.11$322.1K701,309Aug 8, 2022Aug 9, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,335——8,335Jun 10, 2022Jun 23, 2022 ↗View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,335——8,335Jun 10, 2022Jun 13, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
10,750——1,047,700Mar 18, 2022Mar 23, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
10,750——627,216Mar 18, 2022Mar 23, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
40,000——556,466Mar 14, 2022Jan 13, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,000——576,466Mar 14, 2022Jan 13, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
40,000——0Mar 14, 2022Jan 13, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,000——616,466Mar 14, 2022Mar 17, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Feb 22, 2022Feb 24, 2022 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jul 30, 2021Jan 13, 2023 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,000——556,466Jul 30, 2021Jul 30, 2021 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
10,000——516,466Mar 26, 2021Mar 30, 2021 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
10,000——1,058,450Mar 26, 2021Mar 30, 2021 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Feb 19, 2021Feb 23, 2021 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,625——506,466Jul 27, 2020Jul 28, 2020 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,625——490,841Jul 10, 2020Jul 13, 2020 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASE
President, CEO
13,000——475,216Mar 23, 2020Mar 23, 2020 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
SALE
President, CEO
13,000——1,068,450Mar 23, 2020Mar 23, 2020 ↗View →
SUPN
SUPERNUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
281,250——281,250Feb 21, 2020Feb 25, 2020 ↗View →
Other insiders · SUPN
Loading peer insiders…
About this filer
CIK 0001539937
ROLE
President, CEO
PRIMARY
SUPN
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001539937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback